The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...

There are over 55 million people around the world living with Alzheimer’s disease, and this number continues to grow. By 2030 ...

A gentle flicker of light and a steady hum of sound might help slow the course of Alzheimer’s disease. That’s the idea behind ...

A study published in 2023 found that using sleeping pills to get some shut-eye could reduce the buildup of toxic clumps of ...

In this context, researchers have connected neurotoxins from algal blooms to brain changes associated with an ...

The drug, lecanemab, was approved by Health Canada this week. It is the first treatment available in Canada to focus on the ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

An Australian man who was diagnosed with Alzheimer's at the age of 41 has now been told he doesn't have the disease ...

Joining me now is Manoj Bhargava, Founder and CEO of Cerezen. His company is also the largest shareholder of our parent ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

From the Treasure Coast, now to Palm Beach County, a new era of hope for families battling Alzheimer’s and cognitive decline ...